In this episode, Emily speaks with Elan Sudberg, CEO of Alkemist Labs and Chair of the American Herbal Products Association's Psychedelic Plants and Fungi Committee.

The committee was chartered in 2022 to address issues related to the safe use and responsible commerce of lawfully marketed products derived from psychedelic plants and fungi. Elan Sudberg was appointed as the committee's first chair. Already CEO of a committed testing laboratory specialising in plant authentication, botanical ingredient identification and quantitative analytical services to the food and beverage, nutraceutical and cosmeceutical industries, he was a perfect fit. His passion for supporting the roll-out of produce with powerful natural benefits to the masses really comes across in this chat, and in the work he is doing across both roles.

He discusses industry trends, recent acquisitions and their impact on the market, and the tricky business of navigating FDA regulations in this fascinating space. There's plenty to glean from this fascinating discussion, with a really interesting window into the future of the nutraceuticals industry.

To learn more about this topic and the wider nutraceuticals market at Charlton Morris, drop Emily a message on LinkedIn, here, or email at emily.austin@charltonmorris.com.

Hosted on Acast. See acast.com/privacy for more information.